71 – 80 of 151
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.
- Contribution to journal › Article
-
Mark
A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).
- Contribution to journal › Article
-
Mark
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.
- Contribution to journal › Article
-
Mark
Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).
- Contribution to journal › Article
-
Mark
Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden
(2011) XXIII Congress of the International Society on Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 9. p.462-462
- Contribution to journal › Published meeting abstract
-
Mark
Wide temperature range testing with sonoclot plateletfunction and ROTEM EXTEM/FIBTEM/APTEM test
(2011) International congress thrombosis hemostasis In Journal of Thrombosis and Haemostasis 9(s2). p.91-91
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.
- Contribution to journal › Article
-
Mark
Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)
- Contribution to journal › Article
-
Mark
Novel APC-cleavage sites in FVa providing insights into mechanisms of action of APC and its cofactor protein S.
- Contribution to journal › Article
-
Mark
rFVIIa transported from the blood stream into tissues is functionally active
- Contribution to journal › Letter
